A Pilot Study Examining the Effects of Tolvaptan on Residual Renal Function in Peritoneal Dialysis for Diabetics.

Hiramatsu, Takeyuki; Hobo, Akinori; Hayasaki, Takahiro; Kabu, Koki; Furuta, Shinji

Hiramatsu, Takeyuki; Hobo, Akinori; Hayasaki, Takahiro; Kabu, Koki; Furuta, Shinji.

Affiliation

Hiramatsu T; Department of Nephrology, Aichi Welfare Cooperative Agricultural Federation, Konan-Kosei Hospital, Konan-city, Aichi, Japan t-hiramatsu@konan.jaaikosei.or.jp.
Hobo A; Department of Nephrology, Aichi Welfare Cooperative Agricultural Federation, Konan-Kosei Hospital, Konan-city, Aichi, Japan.
Hayasaki T; Department of Nephrology, Aichi Welfare Cooperative Agricultural Federation, Konan-Kosei Hospital, Konan-city, Aichi, Japan.
Kabu K; Baxter Ltd., Chuo-ku, Tokyo, Japan.
Furuta S; Department of Nephrology, Aichi Welfare Cooperative Agricultural Federation, Konan-Kosei Hospital, Konan-city, Aichi, Japan.

Perit Dial Int ; 35(5): 552-8, 2015.

Article in En | MEDLINE | ID: mdl-25082843

Subject(s)
Key words

Kt/V; Peritoneal dialysis; creatinine clearance; end-stage renal disease; tolvaptan; ultrafiltration; urine volume; vasopressin receptor

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzazepines / Peritoneal Dialysis / Diabetes Mellitus / Antidiuretic Hormone Receptor Antagonists / Kidney / Kidney Failure, Chronic Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Perit Dial Int Journal subject: NEFROLOGIA Year: 2015 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google